Solid Tumor, Unspecified, Adult Clinical Trials

8 recruiting

Solid Tumor, Unspecified, Adult Trials at a Glance

8 actively recruiting trials for solid tumor, unspecified, adult are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in New York, The Bronx, and Ponce. Lead sponsors running solid tumor, unspecified, adult studies include Memorial Sloan Kettering Cancer Center, Avelos Therapeutics Inc., and Gustave Roussy, Cancer Campus, Grand Paris.

Browse solid tumor, unspecified, adult trials by phase

Treatments under study

About Solid Tumor, Unspecified, Adult Clinical Trials

Looking for clinical trials for Solid Tumor, Unspecified, Adult? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Solid Tumor, Unspecified, Adult trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Solid Tumor, Unspecified, Adult clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Gustave Roussy Cancer Profiling

Solid Tumor, Unspecified, Adult
Gustave Roussy, Cancer Campus, Grand Paris20,000 enrolled4 locationsNCT04932525
Recruiting
Not Applicable

Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

Solid TumorSolid Tumor, AdultSolid Tumor, Unspecified, Adult
Memorial Sloan Kettering Cancer Center234 enrolled5 locationsNCT04942717
Recruiting
Phase 1Phase 2

Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors

Solid Tumor, Unspecified, Adult
MegaPro Biomedical Co. Ltd.81 enrolled1 locationNCT04643418
Recruiting
Not Applicable

Psychotherapy Intervention for Latinos With Adv Cancer

Solid TumorSolid Tumor, AdultSolid Tumor, Unspecified, Adult
Memorial Sloan Kettering Cancer Center285 enrolled4 locationsNCT04537936
Recruiting
Not Applicable

Psychotherapy Intervention for Latinos With Advanced Cancer

Solid TumorSolid Tumor, AdultSolid Tumor, Unspecified, Adult
Memorial Sloan Kettering Cancer Center190 enrolled4 locationsNCT04015609
Recruiting
Phase 1Phase 2

AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors

Solid TumorSolid Tumor, AdultSolid Tumor Cancer+4 more
Avelos Therapeutics Inc.36 enrolled3 locationsNCT06911333
Recruiting
Phase 1

A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

Pancreas CancerSolid Tumor CancerHCC - Hepatocellular Carcinoma+6 more
LaunXP Biomedical Co., Ltd.24 enrolled2 locationsNCT06883539
Recruiting

Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment

Haematological MalignancySolid Tumor, Unspecified, Adult
Morten Ladekarl3,000 enrolled1 locationNCT05695638